Beyond the Deal: Creating Long-Term Life Sciences Partnerships to Drive Patient Access

When setting up a collaboration that is designed to last for 20+ years and enable development, manufacturing and worldwide commercialisation of critical medicines, the deal structure, governance and contractual allocation of responsibilities and risks play a central role in driving long-term success. This discussion will examine how these are defined, managed and enforced, and how teams can get the balance right between mitigating risk exposure and setting both parties up for success under collaboration and licensing agreements.